Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for glioma.
about
Using magnetic resonance imaging to evaluate dendritic cell-based vaccinationCD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.NKT cell-targeted vaccination plus anti-4-1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma.Chronic alcohol consumption inhibits melanoma growth but decreases the survival of mice immunized with tumor cell lysate and boosted with α-galactosylceramide.Balance is a key for happiness.A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme.ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity.Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines.Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy.Exploiting Antitumor Immunotherapeutic Novel Strategies by Deciphering the Cross Talk between Invariant NKT Cells and Dendritic Cells.In vitro and in vivo antitumor effects of 50 to 100-KDa components from B16 melanoma culture supernatant.Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas.Pharmacological doses of daily ascorbate protect tumors from radiation damage after a single dose of radiation in an intracranial mouse glioma model.Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.Impact of genomics on the surgical management of melanoma.Determining mean fractional anisotropy using DDCOSY: preliminary results in biological tissues.Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model.Whole tumor cell vaccines for glioma immunotherapy.Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia
P2860
Q27316977-18AE0E0E-ECAA-4593-BBEC-79A529A7A501Q34551230-C976E605-1A14-4185-BC5F-40E49F4728E4Q35506745-AC4B4D7A-6DE3-4C19-85FF-5F5B3026E3A5Q36016694-D1549D3A-4C93-439A-BEB5-342D389CE098Q36887825-E54C1A15-1072-40AD-94B5-6E6AA51205E8Q38262123-D4D93FCD-AA3E-4772-B65A-2623BE1D13A7Q38814097-14E9BFDE-7EC8-4137-9B67-21FEA576B866Q38985050-45E0B0F7-7779-4699-9AC0-5D81101E3CCBQ39049093-9A9E99FA-7433-4509-8C70-F7135D0224BEQ40725497-B92150C0-86AC-4459-A813-E5E3C365775BQ41139823-16DF1C6C-F0D1-4F75-8C1F-385D312D6536Q41174284-77AD63F6-E874-450D-A036-86ADB0A614DFQ41550106-60C241CC-3133-4248-8244-D26A0D57EF08Q41617947-739B7B9B-7AAF-41E5-87CB-E09A250F7847Q42625912-AFD3B7D2-74D9-4D7E-ADF4-48A13BF654BDQ49177347-E9502EB2-1E26-4243-BD03-18A39E05C477Q50010320-5BBA1FA8-8191-4554-857F-934F58F87A1AQ51218157-86A1C22A-155B-4386-99C7-384DED78BE45Q52731750-C112773B-0091-4F16-B5FD-F97B6FE20255Q53086671-D7AE0555-57FB-4CB1-99AF-5D3ADC250B51Q57138588-92BC36F9-5FC8-4741-A351-67F7CEA76D59
P2860
Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for glioma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Vaccination with irradiated tu ...... ffective treatment for glioma.
@en
Vaccination with irradiated tu ...... ffective treatment for glioma.
@nl
type
label
Vaccination with irradiated tu ...... ffective treatment for glioma.
@en
Vaccination with irradiated tu ...... ffective treatment for glioma.
@nl
prefLabel
Vaccination with irradiated tu ...... ffective treatment for glioma.
@en
Vaccination with irradiated tu ...... ffective treatment for glioma.
@nl
P2093
P50
P1476
Vaccination with irradiated tu ...... effective treatment for glioma
@en
P2093
Cameron S Field
Kate W R Broadley
Kathryn J Farrand
Martin K Hunn
Rose J Miller
P304
P356
10.1158/1078-0432.CCR-12-0704
P407
P577
2012-11-12T00:00:00Z